About the Authors
- Mariantonia Logozzi
-
Affiliation Unit of Antitumor Drugs, Department of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanità, Rome, Italy
- Angelo De Milito
-
Affiliation Unit of Antitumor Drugs, Department of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanità, Rome, Italy
- Luana Lugini
-
Affiliation Unit of Molecular and Cellular Imaging, Istituto Superiore di Sanità, Rome, Italy
- Martina Borghi
-
Affiliation Unit of Antitumor Drugs, Department of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanità, Rome, Italy
- Luana Calabrò
-
Affiliation Division of Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy
- Massimo Spada
-
Affiliation Unit of Experimental Immunotherapy, Department of Cell Biology and Neurosciences, Istituto Superiore di Sanità, Rome, Italy
- Maurizio Perdicchio
-
Affiliation Unit of Antitumor Drugs, Department of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanità, Rome, Italy
- Maria Lucia Marino
-
Affiliation Unit of Antitumor Drugs, Department of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanità, Rome, Italy
- Cristina Federici
-
Affiliation Unit of Antitumor Drugs, Department of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanità, Rome, Italy
- Elisabetta Iessi
-
Affiliation Unit of Antitumor Drugs, Department of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanità, Rome, Italy
- Daria Brambilla
-
Affiliation Unit of Antitumor Drugs, Department of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanità, Rome, Italy
- Giulietta Venturi
-
Affiliation Unit of Antitumor Drugs, Department of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanità, Rome, Italy
- Francesco Lozupone
-
Affiliation Unit of Antitumor Drugs, Department of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanità, Rome, Italy
- Mario Santinami
-
Affiliation Unit of Melanoma and Sarcoma, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
- Veronica Huber
-
Affiliation Unit of Immunotherapy of Human Tumours, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
- Michele Maio
-
Affiliations Division of Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy, Unit of Cancer Bioimmunotherapy, Department of Medical Oncology, Centro di Riferimento Oncologico IRCCS, Aviano, Italy
- Licia Rivoltini
-
Affiliation Unit of Immunotherapy of Human Tumours, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
- Stefano Fais
-
* E-mail: stefano.fais@iss.it
Affiliation Unit of Antitumor Drugs, Department of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanità, Rome, Italy
Competing Interests
Stefano Fais and Mariantonia Logozzi deposited the patent #US 12/321,412; PCT/EE2009/000001 for the ExoTest described in this work.
Author Contributions
Conceived and designed the experiments: ML ADM LL MP SF. Performed the experiments: ML LL MB MS MP CF DB GV. Analyzed the data: ML ADM LL LC CF EI MS MM LR SF. Contributed reagents/materials/analysis tools: ML LL MB LC MLM EI GV FL MS VH MM LR. Wrote the paper: ML ADM LL LC EI DB FL MS VH MM LR SF.